KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to -$10.7 million.

  • Medpace Holdings' Cash from Investing Activities fell 165.94% to -$10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.2 million, marking a year-over-year decrease of 1908.64%. This contributed to the annual value of -$28.3 million for FY2024, which is 1825.35% up from last year.
  • Medpace Holdings' Cash from Investing Activities amounted to -$10.7 million in Q3 2025, which was down 165.94% from -$6.0 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Cash from Investing Activities ranged from a high of $2.5 million in Q1 2024 and a low of -$12.8 million during Q2 2024
  • Its 5-year average for Cash from Investing Activities is -$8.4 million, with a median of -$9.1 million in 2021.
  • Per our database at Business Quant, Medpace Holdings' Cash from Investing Activities surged by 12662.32% in 2024 and then tumbled by 49474.31% in 2025.
  • Over the past 5 years, Medpace Holdings' Cash from Investing Activities (Quarter) stood at -$9.1 million in 2021, then fell by 1.14% to -$9.2 million in 2022, then grew by 13.26% to -$8.0 million in 2023, then rose by 5.44% to -$7.6 million in 2024, then tumbled by 40.97% to -$10.7 million in 2025.
  • Its last three reported values are -$10.7 million in Q3 2025, -$6.0 million for Q2 2025, and -$10.0 million during Q1 2025.